Marine bacterial extracts as a new rich source of drugs against Alzheimer's disease

Journal of Neurochemistry
Beika ZhuKarl Herrup

Abstract

Alzheimer's disease (AD) is a prevalent, progressive and irreversible, neurodegenerative disease with no disease modifying treatment yet available. The projected burden of AD on our healthcare system is immense and thus there is an immediate need for new drugs that prevent or attenuate AD symptoms. While most efforts in the field are directed at treatments that reduce amyloid or tau burden in the brain, we have taken an alternate approach - a model based on reducing AD-associated neuronal cell cycle events. Using this model, we have screened a largely unexplored source of compounds with therapeutic potential - the natural products created by diverse strains of marine bacteria. Two hundred and twenty-five bacterial extracts from different strains were tested for both toxicity and neuroprotective properties by crystal violet and In-cell Western - first in HT22 cells and then in mouse primary neuronal cultures. Based on these screens, we have identified several promising leads, and here we focus on the most promising of these. We found that we could directly assay even a crude bacterial extract in our E16 mouse cortical neuronal cultures and screen for activities that prevent cell cycle reentry and preserve synaptic structure. Pre...Continue Reading

References

Apr 2, 1987·Nature·R BravoH Macdonald-Bravo
Dec 20, 1985·Science·B M OliveraL J Cruz
Oct 1, 1982·Archives of Biochemistry and Biophysics·M McIntoshB M Olivera
Jul 10, 1995·Neuroreport·U GärtnerT Arendt
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
May 1, 1993·Genes & Development·V BaldinG Draetta
May 26, 1998·Environmental Health Perspectives·E Walum
Jun 14, 2002·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Maria E Bamberger, Gary E Landreth
Oct 5, 2002·Cellular and Molecular Life Sciences : CMLS·C H YamR Y C Poon
Apr 4, 2003·The New England Journal of Medicine·Barry ReisbergUNKNOWN Memantine Study Group
Jun 25, 2003·Drug Discovery Today·Burkhard Haefner
Aug 28, 2003·Brain Research. Molecular Brain Research·Robert A SmithSheng T Hou
Mar 26, 2004·Nature Reviews. Drug Discovery·Andrea WittPeter Kirkpatrick
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan Yang, Karl Herrup
Jul 2, 2005·FEBS Letters·Enrico LeipoldStefan H Heinemann
Oct 6, 2005·Journal of Cellular and Molecular Medicine·Zsuzsanna Nagy
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Samantha Cicero, Karl Herrup
Mar 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·J Steven JacobsenFloyd E Bloom
Dec 13, 2006·Biochimica Et Biophysica Acta·Yan Yang, Karl Herrup
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Günter U HöglingerStéphane Hunot
Apr 25, 2007·Nature Reviews. Neuroscience·Karl Herrup, Yan Yang
Jun 29, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Birgit MoschThomas Arendt
Oct 24, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicholas H VarvelBruce T Lamb
Jan 24, 2009·The American Journal of Pathology·Hyoung-gon LeeMark A Smith
Jan 1, 1989·Toxicology in Vitro : an International Journal Published in Association with BIBRA·K SaotomeM Umeda
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karl Herrup
Jan 25, 2013·Journal of Cell Science·Matthew E SewardGeorge S Bloom
Nov 20, 2013·Journal of Pharmacology & Pharmacotherapeutics·Jaykaran Charan, N D Kantharia
Mar 21, 2015·Lancet Neurology·Michael T HenekaMarkus P Kummer
May 18, 2016·Ageing Research Reviews·Yosef Shiloh, Howard M Lederman
Nov 26, 2016·Orphanet Journal of Rare Diseases·Cynthia Rothblum-OviattHoward M Lederman
Oct 27, 2017·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Jun 30, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong

❮ Previous
Next ❯

Citations

Aug 10, 2021·Archives of Microbiology·Zainab AbdelghaniRouba Hage-Sleiman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.